藥理實(shí)驗(yàn)報(bào)告1_第1頁(yè)
藥理實(shí)驗(yàn)報(bào)告1_第2頁(yè)
藥理實(shí)驗(yàn)報(bào)告1_第3頁(yè)
藥理實(shí)驗(yàn)報(bào)告1_第4頁(yè)
藥理實(shí)驗(yàn)報(bào)告1_第5頁(yè)
已閱讀5頁(yè),還剩1頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

LD50determinationofProcaine

XXXXXXXXXXXXX

(ChinaPharmaceuticalUniversity,Nanjing210009)

AbstractThehalflethaldoseisoneoftheindacaatortoevaluatethedegreeofacutetoxicityofdrug.InthisexperimentwedeterminedtheLD50ofProcaine,wecalculateditbyimprovedKurbermethodandBlissmethod.TheresultsoftheexperimentshowsthattheofProcaineLD50=156.9mg/kg,andthe95%confidenceintervalofLD50is139.4mg/kg~176.6mg/kg.Therefore,Procaineisamedium-toxicity(3-degree)drug.

KeywordsProcaine,LD50,Kurbermethod,Blissmethod

1.IntroductionThelethaldoseisusuallyusedtoevaluatethedegreeofacutetoxicityofthedrug.Halflethaldoseisoneoftheindicatorsbecauseitisthehighestsensitivitypointonthedose-reactioncurve.Acutetoxicity(lethaldose,LD50)canbeviewedas‘cumulativepotential’tocausevariousacuteeffectsanddeathinanimals.Complexendpointssuchasacutetoxicityareamenabletopredictiononlytoalimitedextent,becauseitdependsonamultitudeofvariablesthatareinfluencedbyabroadvarietyofmechanisms.Procaineisalocalanesthetic.Localanesthetics,suchasprocaine,lidocaine,andcocaine,havebeendemonstratedtoprotectneuronaltissueagainsthypoxicdamage.[1]Procainehasbeenusedformorethan90yearsathomeandabroad.[2]ThedeterminationofLD50isarecurrentpharmacology,toxicologyimportantwork.ThecalculationmethodisgenerallybelievedtoBliss'searlyproposedalgorithmarethemostpreciseandaccurate.Butbecauseofitscomplicated,time-consumingmanualcalculationmethod,usingacomputerprogramforthepromotion.[3]

2MaterialandMethods

2.1Material

Animalrequired:44NIHmice,maleandfemale(halfandhalf),weighing14–26g,wereusedthroughoutthedurationofthestudies.Theroomtemperaturewascontrolledbetween18and22°C.

Equipmentrequired:mousecage,balance,andsyringe

Solutionrequired:1%Procaine(BatchNumber:FF120901;10ml×5Ampoules;ShanghaiXudonghaipuCo.;10ml:0.1g),carbazoticacidformarkingthemouse.

2.2Methods

①.Separatethemalefromthefemale,andweighthemrespectively.Putthemiceofthesameweightclass(14.0~15.9g)intothesamemousecage.

②.Markthesamesignalonallthemiceinthesamecage.

③.Randomly,dividethemiceinto5groupsof10miceeachwithsimilarsexandweightintheturnsoftheweightclass(frombigtosmallorininverse).

④.Injectintraperitoneally1%procainetothemiceineachgroupwiththedoseof130mg/kg,153mg/kg,180mg/kg,212mg/kg,249mg/kgrespectivelyusing1:0.85astheratiobetweenadjacentgroups.Numberthedeadineachgroupwithin30min.

⑤.CalculateLD50and95%confidencelimitbyimprovedandBlissmethod.

3.ResultsandDiscussion

Ourgrouptookthepartthatwiththedoseof249mg/kginthewholeexperiment.Thephenomenonisasbelow:

Mousenumber

Mouseweight

(g)

Mouse

gender

(♂&♀)

Timeofdruggiving

(min:s)

Mousesymptomafterdruggiving

Deadtime

(min:s)

Timeofdying

(min:s)

1

25

10:03

Hurrybreathing→Randomwalking→Drifting→Convulsions→Death

13:55

03:52

2

22

08:20

Rigid→Shortnessofbreath→Convulsions→Jump→Hindlimbconvulsions→Death

11:19

02:59

3

17

04:20

Randomwalking→Shortnessofbreath→Convulsions→Death

06:39

02:19

4

18

01:18

Bradykinesia→Shortnessofbreath→Tailturnred→Convulsions→Death

06:00

04:42

5

21

03:08

Shortnessofbreath→Convulsions→Tailturnred→Death

04:55

01:47

6

15

07:18

→Bradykinesia→Shortnessofbreath→Thetwitching→→Convulsions→Hindlimbconvulsions→Tailturnred→Death

10:39

03:21

7

15

14:59

Randomwalk→Shortnessofbreath→Tailturnred→Bradykinesia→Convulsions→Drifting→Jumpseveraltimes→Hindlimbconvulsions→Death

22:54

07:53

8

16

11:14

Bradykinesia→Writhing→Convulsions→Shortnessofbreath→Death

14:06

02:52

9

16

00:00

Shortnessofbreath→Drifting→Bradykinesia→Convulsions→Death

01:30

01:30

3.1ImprovedKurbermethodbySun

TocalculatetheLD50ofProcainebyImprovedKurbermethodweneedthedataincludemicedeathnumber,dosage,micenumberineachgroup.AndthenwecangetthedeathrateP,andLD50withits95%confidenceinterval.

Table1.TheexperimentalresultsofProcaineintraperitonealinjectioninmice

Group

numberofrat

dose(mg/kg)

Logarithmdose

NumberofDeath

Deathrates(P)

P2

1

2

3

4

5

9

9

8

9

9

249

212

180

153

130

2.40

2.33

2.26

2.18

2.11

9

8

6

3

2

1

0.889

0.750

0.333

0.222

1

0.79

0.56

0.11

0.04

P—deathrateineachgroup(expressedwithdecimal)

P2—thesquareofP

Table2.ProcessofProcaineintraperitonealinjectioninmiceresults

∑P

ΣP2

Pm

Pn

Xm

i

3.184

2.513

1

0.222

2.40

0.07

∑p—thetotaladditionofdeathrateineverygroup(p1+p2+p3…..)

∑p2—thesquareofthetotaladditionofdeathrateineverygroup(p12+p22+p32+……)

Pm—thedeathrateingroupwithmaximumdose

Pn—thedeathrateingroupwithminimumdose

Xm—thelogarithmofhighestdose

i—theminusoflogarithmdosesinnearinggroups

LD50=lg-1[Xm-i(Σp-(3-Pm-Pn)/4)]=159.78mg/kg

SlgLD50=i[(ΣP-ΣP2)/(n-1)]?=0.0204

95%confidenceintervalofLD50:lg-1(2.20±0.040)=145.73mg/kg~175.19mg/kg

3.2Blissmethod

UsingLD50CALCversion2.0softwaretoprocesstheexperimentaldataoftheBlissmethod,processingresultsareasfollows:

LD50=156.9mg/kg

95%confidenceintervalofLD50:139.4mg/kg~176.6mg/kg

3.3Discussion

DeterminationofthetoxicityofthedrugsuseddatamayalsoincludeLD90[4],ED50,LD1,LD10,LD5,ED95,ED99andsoon,totheoverallanalysisofdrugtoxicity,toguidethedosage,andthesecurityassessmentofdrug.Becausetheresourcesofmiceislimited,thisexperimentdoesnotmeettherequirementsof10miceineachgroup,themiddledosegroupofmiceisonly8,theremainingdosegroupmicefor9.Thisdefectwillgiveourexperimentresult.

Forthejudgmentofmicetodeath,therespirationandheartbeat,shouldbecarefullyobserved,therearemiceintermittenttremorisnotdeath.Asthehighdosegroupoftheexperiment,miceshowedsymptomsappearsoonaftergavedrug,mainlyforthefirstlyexcited,andthenactivityweakened,rathairerect,hindlegspedaling.Neardeath,miceasweakness,trembling,vitalsignsgraduallydisappear.

ThecurveofDeathRate-Doseistransformedtoanothercurvewithfeaturesofthesymmetryoftheleftandrightandthepointofsymmetryin50%deathratebyusinglogarithmtransformeddoseasabscissa.Atthepoint,theslopeismaximumandthechangeisobvious.Thatistosaythatthereactionoftheanimaltothedrugdoseismostsensitive,anddoseisthemostaccurateanderrorisminimum.SowechooseLD50toevaluatethedegreeofacutetoxicityofthedrug.

Thedefectsintheexperiment:

1、Theweightdifference,14~26g.

2、Theamountofmiceisnotenough,thisexperimentcancostalotofanimals.

3,Thecleangradecannotreachthestandardofmice(SPF).

4,Thetemperatureofenvironmental,humidityandotherfactorsdidnotgetundercontrol.

5,Manualoperationisnotstandard,suchasintraperitonealinjectionoperationmaybenotstandard,thiscaninfluencetheexperimentresult.

4.Conclusion

TheresultsshowedthattheLD50and95%confidenceintervalofLD50arealittledifferentbydifferentmethod.AsknownthatBlissmethodisthemostrigorousmethodmathematicallyamongmanycalculationmethodsofLD50andisrecommendedinthemethodofexaminationandapprovalofnewdrugs,wetaketheresultofBlissmethod.AsLD50=

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論